NRG Oncology/RTOG 1119: PHASE II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery with Concurrent Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer - A Collaborative Study of NRG and KROG (NCT01622868) Other Scholarly Work

Kim, IA, Moughan, J, Sperduto, PW et al. (2020). NRG Oncology/RTOG 1119: PHASE II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery with Concurrent Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer - A Collaborative Study of NRG and KROG (NCT01622868) . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108(3), S174-S175.

International Collaboration

cited authors

  • Kim, IA; Moughan, J; Sperduto, PW; De Los Santos, JF; Peereboom, D; Ogunleye, TB; Boulter, D; Cho, KH; Shin, KH; Zoberi, I; Choi, S; Palmer, JD; Liem, B; Kim, YB; Anderson, BM; Thakrar, A; Muanz, TM; Choi, DH; Kim, MM; Mehta, MP; White, JR

sustainable development goals

authors

publication date

  • November 1, 2020

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • ELECTR NETWORK

publisher

  • ELSEVIER SCIENCE INC

start page

  • S174

end page

  • S175

volume

  • 108

issue

  • 3